Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone, aripiprazole, and haloperidol in first-episode early-onset schizophrenia spectrum disorders
2009-017024-82Phase 3Terminated
- Sponsor
- Fundació Sant Joan de Déu
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of paliperidone, aripiprazole and haloperidol in Schizophrenia Spectrum and Other Psychotic Disorders (SZ) and Simple-type schizophrenia (3 arms), sponsored by Fundació Sant Joan de Déu. Primary endpoints: Treatment response at end of acute stage and All-cause treatment discontinuation. Started Nov 2009; status: terminated.
02
Drugs
paliperidonearipiprazolehaloperidol
03
Conditions
Schizophrenia Spectrum and Other Psychotic Disorders (SZ)Simple-type schizophrenia
Beyond the preview
Go deeper on 2009-017024-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017024-82.